Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Therapy for Bladder Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Atezolizumab (Tecentriq)
1.2.3 Avelumab (Bavencio)
1.2.4 Erdafitinib (Balversa)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Targeted Therapy for Bladder Cancer Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Therapy for Bladder Cancer Market Perspective (2018-2029)
2.2 Targeted Therapy for Bladder Cancer Growth Trends by Region
2.2.1 Global Targeted Therapy for Bladder Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Therapy for Bladder Cancer Historic Market Size by Region (2018-2024)
2.2.3 Targeted Therapy for Bladder Cancer Forecasted Market Size by Region (2024-2029)
2.3 Targeted Therapy for Bladder Cancer Market Dynamics
2.3.1 Targeted Therapy for Bladder Cancer Industry Trends
2.3.2 Targeted Therapy for Bladder Cancer Market Drivers
2.3.3 Targeted Therapy for Bladder Cancer Market Challenges
2.3.4 Targeted Therapy for Bladder Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Therapy for Bladder Cancer Players by Revenue
3.1.1 Global Top Targeted Therapy for Bladder Cancer Players by Revenue (2018-2024)
3.1.2 Global Targeted Therapy for Bladder Cancer Revenue Market Share by Players (2018-2024)
3.2 Global Targeted Therapy for Bladder Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Therapy for Bladder Cancer Revenue
3.4 Global Targeted Therapy for Bladder Cancer Market Concentration Ratio
3.4.1 Global Targeted Therapy for Bladder Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Therapy for Bladder Cancer Revenue in 2022
3.5 Targeted Therapy for Bladder Cancer Key Players Head office and Area Served
3.6 Key Players Targeted Therapy for Bladder Cancer Product Solution and Service
3.7 Date of Enter into Targeted Therapy for Bladder Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Therapy for Bladder Cancer Breakdown Data by Type
4.1 Global Targeted Therapy for Bladder Cancer Historic Market Size by Type (2018-2024)
4.2 Global Targeted Therapy for Bladder Cancer Forecasted Market Size by Type (2024-2029)
5 Targeted Therapy for Bladder Cancer Breakdown Data by Application
5.1 Global Targeted Therapy for Bladder Cancer Historic Market Size by Application (2018-2024)
5.2 Global Targeted Therapy for Bladder Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Therapy for Bladder Cancer Market Size (2018-2029)
6.2 North America Targeted Therapy for Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024)
6.4 North America Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Therapy for Bladder Cancer Market Size (2018-2029)
7.2 Europe Targeted Therapy for Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024)
7.4 Europe Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Therapy for Bladder Cancer Market Size (2018-2029)
8.2 Asia-Pacific Targeted Therapy for Bladder Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeted Therapy for Bladder Cancer Market Size by Region (2018-2024)
8.4 Asia-Pacific Targeted Therapy for Bladder Cancer Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Therapy for Bladder Cancer Market Size (2018-2029)
9.2 Latin America Targeted Therapy for Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024)
9.4 Latin America Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Therapy for Bladder Cancer Market Size (2018-2029)
10.2 Middle East & Africa Targeted Therapy for Bladder Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024)
10.4 Middle East & Africa Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Targeted Therapy for Bladder Cancer Introduction
11.1.4 Pfizer Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Targeted Therapy for Bladder Cancer Introduction
11.2.4 Merck KGaA Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.2.5 Merck KGaA Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Targeted Therapy for Bladder Cancer Introduction
11.3.4 Roche Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.3.5 Roche Recent Development
11.4 Astellas
11.4.1 Astellas Company Detail
11.4.2 Astellas Business Overview
11.4.3 Astellas Targeted Therapy for Bladder Cancer Introduction
11.4.4 Astellas Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.4.5 Astellas Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Targeted Therapy for Bladder Cancer Introduction
11.5.4 Janssen Biotech Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.5.5 Janssen Biotech Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Targeted Therapy for Bladder Cancer Introduction
11.6.4 Bristol-Myers Squibb Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Detail
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Targeted Therapy for Bladder Cancer Introduction
11.7.4 Merck & Co. Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.7.5 Merck & Co. Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Targeted Therapy for Bladder Cancer Introduction
11.8.4 Gilead Sciences Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Targeted Therapy for Bladder Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Atezolizumab (Tecentriq)
Table 3. Key Players of Avelumab (Bavencio)
Table 4. Key Players of Erdafitinib (Balversa)
Table 5. Key Players of Other
Table 6. Global Targeted Therapy for Bladder Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Targeted Therapy for Bladder Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Targeted Therapy for Bladder Cancer Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Targeted Therapy for Bladder Cancer Market Share by Region (2018-2024)
Table 10. Global Targeted Therapy for Bladder Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Targeted Therapy for Bladder Cancer Market Share by Region (2024-2029)
Table 12. Targeted Therapy for Bladder Cancer Market Trends
Table 13. Targeted Therapy for Bladder Cancer Market Drivers
Table 14. Targeted Therapy for Bladder Cancer Market Challenges
Table 15. Targeted Therapy for Bladder Cancer Market Restraints
Table 16. Global Targeted Therapy for Bladder Cancer Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Targeted Therapy for Bladder Cancer Market Share by Players (2018-2024)
Table 18. Global Top Targeted Therapy for Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Bladder Cancer as of 2022)
Table 19. Ranking of Global Top Targeted Therapy for Bladder Cancer Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Targeted Therapy for Bladder Cancer Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Targeted Therapy for Bladder Cancer Product Solution and Service
Table 23. Date of Enter into Targeted Therapy for Bladder Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Targeted Therapy for Bladder Cancer Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Targeted Therapy for Bladder Cancer Revenue Market Share by Type (2018-2024)
Table 27. Global Targeted Therapy for Bladder Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Targeted Therapy for Bladder Cancer Revenue Market Share by Type (2024-2029)
Table 29. Global Targeted Therapy for Bladder Cancer Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Targeted Therapy for Bladder Cancer Revenue Market Share by Application (2018-2024)
Table 31. Global Targeted Therapy for Bladder Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Targeted Therapy for Bladder Cancer Revenue Market Share by Application (2024-2029)
Table 33. North America Targeted Therapy for Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Targeted Therapy for Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Targeted Therapy for Bladder Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Targeted Therapy for Bladder Cancer Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Targeted Therapy for Bladder Cancer Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Targeted Therapy for Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Targeted Therapy for Bladder Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Targeted Therapy for Bladder Cancer Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Targeted Therapy for Bladder Cancer Market Size by Country (2024-2029) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Targeted Therapy for Bladder Cancer Product
Table 51. Pfizer Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Merck KGaA Company Detail
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Targeted Therapy for Bladder Cancer Product
Table 56. Merck KGaA Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 57. Merck KGaA Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Targeted Therapy for Bladder Cancer Product
Table 61. Roche Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Astellas Company Detail
Table 64. Astellas Business Overview
Table 65. Astellas Targeted Therapy for Bladder Cancer Product
Table 66. Astellas Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 67. Astellas Recent Development
Table 68. Janssen Biotech Company Detail
Table 69. Janssen Biotech Business Overview
Table 70. Janssen Biotech Targeted Therapy for Bladder Cancer Product
Table 71. Janssen Biotech Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 72. Janssen Biotech Recent Development
Table 73. Bristol-Myers Squibb Company Detail
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Targeted Therapy for Bladder Cancer Product
Table 76. Bristol-Myers Squibb Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Merck & Co. Company Detail
Table 79. Merck & Co. Business Overview
Table 80. Merck & Co. Targeted Therapy for Bladder Cancer Product
Table 81. Merck & Co. Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 82. Merck & Co. Recent Development
Table 83. Gilead Sciences Company Detail
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Targeted Therapy for Bladder Cancer Product
Table 86. Gilead Sciences Revenue in Targeted Therapy for Bladder Cancer Business (2018-2024) & (US$ Million)
Table 87. Gilead Sciences Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Therapy for Bladder Cancer Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Targeted Therapy for Bladder Cancer Market Share by Type: 2022 VS 2029
Figure 3. Atezolizumab (Tecentriq) Features
Figure 4. Avelumab (Bavencio) Features
Figure 5. Erdafitinib (Balversa) Features
Figure 6. Other Features
Figure 7. Global Targeted Therapy for Bladder Cancer Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Targeted Therapy for Bladder Cancer Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Targeted Therapy for Bladder Cancer Report Years Considered
Figure 13. Global Targeted Therapy for Bladder Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Targeted Therapy for Bladder Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Targeted Therapy for Bladder Cancer Market Share by Region: 2022 VS 2029
Figure 16. Global Targeted Therapy for Bladder Cancer Market Share by Players in 2022
Figure 17. Global Top Targeted Therapy for Bladder Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Bladder Cancer as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Therapy for Bladder Cancer Revenue in 2022
Figure 19. North America Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Targeted Therapy for Bladder Cancer Market Share by Country (2018-2029)
Figure 21. United States Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Targeted Therapy for Bladder Cancer Market Share by Country (2018-2029)
Figure 25. Germany Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Targeted Therapy for Bladder Cancer Market Share by Region (2018-2029)
Figure 33. China Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Targeted Therapy for Bladder Cancer Market Share by Country (2018-2029)
Figure 41. Mexico Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Targeted Therapy for Bladder Cancer Market Share by Country (2018-2029)
Figure 45. Turkey Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Targeted Therapy for Bladder Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 48. Merck KGaA Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 49. Roche Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 50. Astellas Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 51. Janssen Biotech Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 53. Merck & Co. Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 54. Gilead Sciences Revenue Growth Rate in Targeted Therapy for Bladder Cancer Business (2018-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed